A phase lb study of ribociclib in combination with doxorubicin in advanced soft tissue sarcomas (aSTS).

被引:0
|
作者
Davis, Lara E.
Latour, Emile
Burch, Reid
Park, Byung
Davis, Jessica L.
Ryan, Christopher W.
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
11548
引用
收藏
页数:2
相关论文
共 50 条
  • [41] A phase II study of Doxil (liposomal doxorubicin): Lack of activity in poor prognosis soft tissue sarcomas
    Garcia, AA
    Kempf, RA
    Rogers, M
    Muggia, FM
    ANNALS OF ONCOLOGY, 1998, 9 (10) : 1131 - 1133
  • [42] A phase II study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcomas
    Trucco, Matteo M.
    Meyer, Christian F.
    Thornton, Katherine A.
    Shah, Preeti
    Chen, Allen R.
    Wilky, Breelyn A.
    Carrera-Haro, Maria A.
    Boyer, Lillian C.
    Ferreira, Margaret F.
    Shafique, Umber
    Powell, Jonathan D.
    Loeb, David M.
    CLINICAL SARCOMA RESEARCH, 2018, 8
  • [43] Pazopanib in advanced soft tissue sarcomas
    Lee, Alex T. J.
    Jones, Robin L.
    Huang, Paul H.
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4
  • [44] Pazopanib in advanced soft tissue sarcomas
    Alex T. J. Lee
    Robin L. Jones
    Paul H. Huang
    Signal Transduction and Targeted Therapy, 4
  • [45] Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma
    Blay, Jean-Yves
    von Mehren, Margaret
    Samuels, Brian L.
    Fanucchi, Michael P.
    Ray-Coquard, Isabelle
    Buckley, Brigid
    Gilles, Leen
    Lebedinsk, Claudia
    Elsayed, Yusri A.
    Le Cesne, Axel
    CLINICAL CANCER RESEARCH, 2008, 14 (20) : 6656 - 6662
  • [46] First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: A Phase I/II open-label and double-blind study
    Demetri, George D.
    Le Cesne, Axel
    Chawla, Sant P.
    Brodowicz, Thomas
    Maki, Robert G.
    Bach, Bruce A.
    Smethurst, Dominic P.
    Bray, Sarah
    Hei, Yong-jiang
    Blay, Jean-Yves
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (04) : 547 - 563
  • [47] Synergistic activities of Panobinostat and doxorubicin in soft tissue sarcomas
    Zhang, Yingjun
    Wong, C. H.
    Hui, Connie W. C.
    Tse, Teresa
    Yeung, Vanessa
    Cheung, Kingsley
    Tao, Qian
    Loong, Herbert H.
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 176
  • [48] High Dose Doxorubicin-Ifosfamide (HDDI) Combination Therapy for Soft Tissue Sarcomas (STS)
    Arganaraz, F.
    Chacon, M.
    Kaplan, J.
    Chacon, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S670 - S670
  • [49] Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study
    Martin-Broto, Javier
    Lopez Pousa, Antonio
    de las Penas, Ramon
    Garcia del Muro, Xavier
    Gutierrez, Antonio
    Martinez-Trufero, Javier
    Cruz, Josefina
    Alvarez, Rosa
    Cubedo, Ricardo
    Redondo, Andres
    Maurel, Joan
    Carrasco, Juan A.
    Lopez-Martin, Jose A.
    Sala, Angeles
    Andres Meana, Jose
    Ramos, Rafael
    Martinez-Serra, Jordi
    Lopez-Guerrero, Jose A.
    Sevilla, Isabel
    Balana, Carmen
    Vaz, Angeles
    De Juan, Ana
    Alemany, Regina
    Poveda, Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (19) : 2294 - +
  • [50] Phase II study with prolonged infusion gemcitabine in pretreated advanced soft tissue sarcomas of the adult
    Späth-Schwalbe, E
    Genvresse, I
    Koschuth, A
    Grunewald, R
    Possinger, K
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S271 - S271